1.            Akbarzadeha R, Yu X, Vogl T, Ludwig RJ, Schmidt E, Zillikens D, Petersen F. Myeloid-related proteins-8 and-14 are expressed but dispensable in the pathogenesis of experimental epidermolysis bullosa acquisita and bullous pemphigoid.
Journal of dermatological science 81:165-172.2016.

2.            Cypers H, Varkas G, Beeckman S, Debusschere K, Vogl T, Roth J, Drennan MB, Lavric M, Foell D, Cuvelier CA, De Vos M, Delanghe J, Van den Bosch F, Elewaut D. Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis.
Annals of the Rheumatic Diseases 75:1357-1362.2016.

3.            Daebritz J, Weinhage T, Varga G, Wirth T, Ehrchen JM, Barczyk-Kahlert K, Roth J, Schwarz T, Foell D. Activation-dependent cell death of human monocytes is a novel mechanism of fine-tuning inflammation and autoimmunity.
European Journal of Immunology 46:1997-2007.2016.

4.            de Munter W, van den Bosch MH, Sloetjes AW, Croce KJ, Vogl T, Roth J, Koenders MI, de Loo FAv, van den Berg WB, van der Kraan PM, van Lent PL. High LDL levels lead to increased synovial inflammation and accelerated ectopic bone formation during experimental osteoarthritis.
Osteoarthritis and Cartilage 24:844-855.2016.

5.            Geven EJW, van den Bosch MHJ, Di Ceglie I, Ascone G, Abdollahi-Roodsaz S, Sloetjes AW, Hermann S, Schaefers M, van de Loo FAJ, van der Kraan PM, Koenders MI, Foell D, Roth J, Vogl T, van Lent PLEM. S100A8/A9, a potent serum and molecular imaging biomarker for synovial inflammation and joint destruction in seronegative experimental arthritis.
Arthritis Research & Therapy 18.2016.

6.            Holzinger D, Roth J. Alarming consequences - autoinflammatory disease spectrum due to mutations in proline- serinethreonine phosphatase- interacting protein 1.
Current Opinion in Rheumatology 28:550-559.2016.

7.            Hucke S, Eschborn M, Liebmann M, Herold M, Freise N, Engbers A, Ehling P, Meuth SG, Roth J, Kuhlmann T, Wiendl H, Klotz L. Sodium chloride promotes pro-inflammatory macrophage polarization thereby aggravating CNS autoimmunity.
Journal of Autoimmunity 67:90-101.2016.

8.            Hucke S, Herold M, Liebmann M, Freise N, Lindner M, Fleck A-K, Zenker S, Thiebes S, Fernandez-Orth J, Buck D, Luessi F, Meuth SG, Zipp F, Hemmer B, Engel DR, Roth J, Kuhlmann T, Wiendl H, Klotz L. The farnesoid-X-receptor in myeloid cells controls CNS autoimmunity in an IL-10-dependent fashion.
Acta neuropathologica 132:413-431.2016.

9.            Nair SC, Welsing PMJ, Choi IYK, Roth J, Holzinger D, Bijlsma JWJ, van Laar JM, Gerlag DM, Lafeber FPJG, Tak PP. A Personalized Approach to Biological Therapy Using Prediction of Clinical Response Based on MRP8/14 Serum Complex Levels in Rheumatoid Arthritis Patients.
PloS one 11.2016.

10.          Nowacki TM, Remaley AT, Bettenworth D, Eisenblaetter M, Vowinkel T, Becker F, Vogl T, Roth J, Tietge UJ, Luegering A, Heidemann J, Nofer J-R. The 5A apolipoprotein A-I (apoA-I) mimetic peptide ameliorates experimental colitis by regulating monocyte infiltration.
British journal of pharmacology 173:2780-2792.2016.

11.          Ohl K, Wiener A, Lippe R, Schippers A, Zorn C, Roth J, Wagner N, Tenbrock K. CREM Alpha Enhances IL-21 Production in T Cells In Vivo and In Vitro.
Frontiers in Immunology 7.2016.

12.          Pruenster M, Vogl T, Roth J, Sperandio M. S100A8/A9: From basic science to clinical application.
Pharmacology & Therapeutics 167:120-131.2016.

13.          Rekers NV, Bajema IM, Mallat MJK, Petersen B, Anholts JDH, Swings GMJS, van Miert PPMC, Kerkhoff C, Roth J, Popp D, van Groningen MC, Baeten D, Goemaere N, Kraaij MD, Zandbergen M, Heidt S, van Kooten C, de Fijter JW, Claas FHJ, Eikmans M. Beneficial Immune Effects of Myeloid-Related Proteins in Kidney Transplant Rejection.
American Journal of Transplantation 16:1441-1455.2016.

14.          Schelbergen RFP, de Munter W, van den Bosch MHJ, Lafeber FPJG, Sloetjes A, Vogl T, Roth J, van den Berg WB, van der Kraan PM, Blom AB, van Lent PLEM. Alarmins S100A8/S100A9 aggravate osteophyte formation in experimental osteoarthritis and predict osteophyte progression in early human symptomatic osteoarthritis.
Annals of the Rheumatic Diseases 75:218-225.2016.

15.          Van Crombruggen K, Vogl T, Perez-Novo C, Holtappels G, Bachert C. Differential release and deposition of S100A8/A9 proteins in inflamed upper airway tissue.
European Respiratory Journal 47:264-274.2016.

16.          van den Bosch MH, Blom AB, Schelbergen RF, Koenders MI, van de Loo FA, van den Berg WB, Vogl T, Roth J, van der Kraan PM, van Lent PL. Alarmin S100A9 Induces Proinflammatory and Catabolic Effects Predominantly in the M1 Macrophages of Human Osteoarthritic Synovium.
Journal of Rheumatology 43:1874-1884.2016.

17.          Wales P, Schuberth CE, Aufschnaiter R, Fels J, Garcia-Aguilar I, Janning A, Dlugos CP, Schaefer-Herte M, Klingner C, Waelte M, Kuhlmann J, Menis E, Kang LH, Maier KC, Hou W, Russo A, Higgs HN, Pavenstaedt H, Vogl T, Roth J, Qualmann B, Kessels MM, Martin DE, Mulder B, Wedlich-Soeldner R. Calcium-mediated actin reset (CaAR) mediates acute cell adaptations.
Elife 5.2016.

18.          Wilsmann-Theis D, Wagenpfeil J, Holzinger D, Roth J, Koch S, Schnautz S, Bieber T, Wenzel J. Among the S100 proteins, S100A12 is the most significant marker for psoriasis disease activity.
Journal of the European Academy of Dermatology and Venereology 30:1165-1170.2016.

19.          Zambetti NA, Ping Z, Chen S, Kenswil KJG, Mylona MA, Sanders MA, Hoogenboezem RM, Bindels EMJ, Adisty MN, Van Strien PMH, van der Leije CS, Westers TM, Cremers EMP, Milanese C, Mastroberardino PG, van Leeuwen JPTM, van der Eerden BCJ, Touw IP, Kuijpers TW, Kanaar R, de Loosdrecht AAv, Vogl T, Raaijmakers MHGP. Mesenchymal Inflammation Drives Genotoxic Stress in Hematopoietic Stem Cells and Predicts Disease Evolution in Human Pre-leukemia. Cell Stem Cell 19:613-627.2016.